Redhill Biopharma Starts Recruitment For Phase 2 Opaganib/darolutamide Combo Study In Advanced Prostate Cancer Read More » July 2, 2025
LIfT BioSciences Expands U.S. Footprint with New Facility at Portal Innovations Read More » June 25, 2025
Integrated DNA Technologies Announces Innovation Roadmap Advances to Infectious Disease Portfolio Read More » June 16, 2025